195 related articles for article (PubMed ID: 19013746)
1. Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study.
Gemer O; Gdalevich M; Voldarsky M; Barak F; Ben Arie A; Schneider D; Levy T; Anteby EY; Lavie O
Eur J Surg Oncol; 2009 Aug; 35(8):865-9. PubMed ID: 19013746
[TBL] [Abstract][Full Text] [Related]
2. Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma.
Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S
J Reprod Med; 2004 Sep; 49(9):703-6. PubMed ID: 15493559
[TBL] [Abstract][Full Text] [Related]
3. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study.
Gemer O; Arie AB; Levy T; Gdalevich M; Lorian M; Barak F; Anteby E; Lavie O
Eur J Surg Oncol; 2007 Jun; 33(5):644-7. PubMed ID: 17317084
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
6. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
7. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
8. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
9. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
10. Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.
Phelan C; Montag AG; Rotmensch J; Waggoner SE; Yamada SD; Mundt AJ
Gynecol Oncol; 2001 Dec; 83(3):513-7. PubMed ID: 11733964
[TBL] [Abstract][Full Text] [Related]
11. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
[TBL] [Abstract][Full Text] [Related]
15. The outcome of patients with stage I endometrial cancer involving the lower uterine segment.
Lavie O; Uriev L; Gdalevich M; Barak F; Peer G; Auslender R; Anteby E; Gemer O
Int J Gynecol Cancer; 2008; 18(5):1079-83. PubMed ID: 18081795
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion.
Croog VJ; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2008 Oct; 111(1):49-54. PubMed ID: 18639922
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
[TBL] [Abstract][Full Text] [Related]
18. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy.
Kadar N; Malfetano JH; Homesley HD
Obstet Gynecol; 1992 Oct; 80(4):655-9. PubMed ID: 1407890
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
